Chemoinformaics analysis of 2-(Methylamino)benzaldehyde
| Molecular Weight | 135.166 | nRot | 2 |
| Heavy Atom Molecular Weight | 126.094 | nRig | 7 |
| Exact Molecular Weight | 135.068 | nRing | 1 |
| Solubility: LogS | -2.551 | nHRing | 0 |
| Solubility: LogP | 1.772 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 21.2631 |
| nHD | 1 | BPOL | 10.4669 |
| QED | 0.623 |
| Synth | 2.01 |
| Natural Product Likeliness | -0.341 |
| NR-PPAR-gamma | 0.047 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.007 |
| HIA | 0.009 |
| CACO-2 | -4.495 |
| MDCK | 0.0000264 |
| BBB | 0.959 |
| PPB | 0.661392 |
| VDSS | 1.373 |
| FU | 0.342714 |
| CYP1A2-inh | 0.931 |
| CYP1A2-sub | 0.609 |
| CYP2c19-inh | 0.289 |
| CYP2c19-sub | 0.572 |
| CYP2c9-inh | 0.137 |
| CYP2c9-sub | 0.816 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.797 |
| CYP3a4-inh | 0.054 |
| CYP3a4-sub | 0.163 |
| CL | 8.047 |
| T12 | 0.779 |
| hERG | 0.016 |
| Ames | 0.317 |
| ROA | 0.041 |
| SkinSen | 0.75 |
| Carcinogencity | 0.202 |
| EI | 0.992 |
| Respiratory | 0.974 |
| NR-Aromatase | 0.01 |
| Antiviral | No |
| Prediction | 0.887946 |